New Omicron subvariant BQ.1.1 resistant to all therapeutic antibodies
Are the currently approved antibody therapies used to treat individuals at increased risk for severe COVID-19 disease also effective against ...
Tag: BQ.1.1
-
Null results research now published by major behavioral medicine journal
-
New study shows snacking on mixed tree nuts may impact cardiovascular risk factors and increase serotonin
-
Cambridge-led consortium receives $35m to boost crop production sustainably in sub-Saharan Africa
-
This groundbreaking biomaterial heals tissues from the inside out
-
Under pressure: Breakthrough new material solves problem of wearable sensors
-
COVID-19 is a leading cause of death in children and young people in the United States